Xeris Biopharma Holdings Inc. buy Craig Hallum
Start price
28.08.23
/
50%
€2.12
Target price
28.08.24
€4.16
Performance (%)
20.38%
End price
29.08.24
€2.55
Summary
This prediction ended on 29.08.24 with a price of €2.55. The prediction had a final performance of 20.38%. Craig_Hallum has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Xeris Biopharma Holdings Inc. | -3.097% | -3.097% | 63.439% |
iShares Core DAX® | -1.471% | 1.895% | 25.178% |
iShares Nasdaq 100 | -0.486% | 4.395% | 29.415% |
iShares Nikkei 225® | -2.115% | 2.450% | 20.561% |
iShares S&P 500 | 0.394% | 3.118% | 29.456% |
Comments by Craig_Hallum for this prediction
In the thread Xeris Biopharma Holdings Inc. diskutieren
Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $4.50 price target on the stock.
Ratings data for XERS provided by MarketBeat
In the thread Trading Xeris Biopharma Holdings Inc.
Die von Craig_Hallum gewählte maximale Laufzeit wurde überschritten